Intel Strategy for Achieving Wealth and Off Topic Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Intel Strategy for Achieving Wealth and Off Topic

INTC 41.41

+2.2%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Frank Ellis Morris who wrote (17770)	2/23/1998 10:04:00 PM
From: Sonny McWilliams	Read Replies (1) of 27012

Good evening Frank. Yes, Merck is looking good. Along with all the things in their pipeline this new Asthma drug is projected to generate 1/2 bill. in sales. There is only one big problem again. Glaxo once again has cancelled a merger, or I guess both Glx and Smith Kline have cancelled the deal. I think Smith Kline said it was not in their cos. interest. I heard they could not agree on who would be running the company. This is a very strange situation. The stock of Glaxo keeps running up on merger talk, then it is being cancelled and the stocks drops like a stone. Then we go on to another merger talk and same thing happens. What makes me wonder is which shareholders of Glaxo benefit the most from all this. I would think if the little guy who goes in after the merger talk is announced could be hurting the most. I am glad I did not go into Glaxo either time. So, let's hope this cancelled merger talk is not going to weigh badly on the drug stocks tomorrow. At least CPQ participated in the up move in our techs today. Sonny

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next